Literature DB >> 22547698

Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection.

Christine J Hastey1, Rebecca A Elsner, Stephen W Barthold, Nicole Baumgarth.   

Abstract

B cell responses modulate disease during infection with Borrelia burgdorferi, the causative agent of Lyme disease, but are unable to clear the infection. Previous studies have demonstrated that B. burgdorferi infection induces predominantly T-independent B cell responses, potentially explaining some of these findings. However, others have shown effects of T cells on the isotype profile and the magnitude of the B. burgdorferi-specific Abs. This study aimed to further investigate the humoral response to B. burgdorferi and its degree of T cell dependence, with the ultimate goal of elucidating the mechanisms underlying the failure of effective immunity to this emerging infectious disease agent. Our study identifies distinct stages in the B cell response using a mouse model, all marked by the generation of unusually strong and persistent T-dependent and T-independent IgM Abs. The initial phase is dominated by a strong T-independent accumulation of B cells in lymph nodes and the induction of specific Abs in the absence of germinal centers. A second phase begins around week 2.5 to 3, in which relatively short-lived germinal centers develop in lymph nodes, despite a lymph node architecture that lacks clearly demarcated T and B cell zones. This response failed, however, to generate appreciable numbers of long-lived bone marrow plasma cells. Finally, there is a slow accumulation of long-lived Ab-secreting plasma cells in bone marrow, reflected by a strong but ultimately ineffective serum Ab response. Overall, the study indicates that B. burgdorferi might evade B cell immunity by interfering with its response kinetics and quality.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547698      PMCID: PMC3358496          DOI: 10.4049/jimmunol.1103735

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP.

Authors:  M J Czar; E N Kersh; L A Mijares; G Lanier; J Lewis; G Yap; A Chen; A Sher; C S Duckett; R Ahmed; P L Schwartzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

3.  Cutting edge: T cell-mediated pathology in murine Lyme borreliosis.

Authors:  M D McKisic; W L Redmond; S W Barthold
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

4.  Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.

Authors:  R A Kalish; G McHugh; J Granquist; B Shea; R Ruthazer; A C Steere
Journal:  Clin Infect Dis       Date:  2001-08-10       Impact factor: 9.079

5.  T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease.

Authors:  M D McKisic; S W Barthold
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes.

Authors:  Kishore R Alugupalli; Rachel M Gerstein; Jianzhu Chen; Eva Szomolanyi-Tsuda; Robert T Woodland; John M Leong
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

8.  Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.

Authors:  Robert R Müllegger; Terry K Means; Junghee J Shin; Marshall Lee; Kathryn L Jones; Lisa J Glickstein; Andrew D Luster; Allen C Steere
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

9.  CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.

Authors:  P Schaerli; K Willimann; A B Lang; M Lipp; P Loetscher; B Moser
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.

Authors:  D Breitfeld; L Ohl; E Kremmer; J Ellwart; F Sallusto; M Lipp; R Förster
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  48 in total

Review 1.  The regulation of T follicular helper responses during infection.

Authors:  Noah S Butler; Divine I Kulu
Journal:  Curr Opin Immunol       Date:  2015-03-02       Impact factor: 7.486

2.  BB0744 Affects Tissue Tropism and Spatial Distribution of Borrelia burgdorferi.

Authors:  Beau Wager; Dana K Shaw; Ashley M Groshong; Jon S Blevins; Jon T Skare
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

3.  MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Authors:  Christine J Hastey; Jennine Ochoa; Kimberley J Olsen; Stephen W Barthold; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

Review 4.  Pathogen manipulation of B cells: the best defence is a good offence.

Authors:  Katharina Nothelfer; Philippe J Sansonetti; Armelle Phalipon
Journal:  Nat Rev Microbiol       Date:  2015-02-09       Impact factor: 60.633

5.  Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Authors:  Diane G Edmondson; Sabitha Prabhakaran; Steven J Norris; Amy J Ullmann; Joe Piesman; Marc Dolan; Christian Probst; Christiane Radzimski; Winfried Stöcker; Lars Komorowski
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

6.  CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection.

Authors:  Rebecca A Elsner; Christine J Hastey; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

7.  MyD88 Signaling in T Cells Is Critical for Effector CD4 T Cell Differentiation following a Transitional T Follicular Helper Cell Stage.

Authors:  Rajakumar Mandraju; Aakanksha Jain; Yajing Gao; Zhiming Ouyang; Michael V Norgard; Chandrashekhar Pasare
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

8.  Protective neutralizing influenza antibody response in the absence of T follicular helper cells.

Authors:  Kosuke Miyauchi; Akiko Sugimoto-Ishige; Yasuyo Harada; Yu Adachi; Yoshiko Usami; Tomohiro Kaji; Kentaro Inoue; Hideki Hasegawa; Takashi Watanabe; Atsushi Hijikata; Satoshi Fukuyama; Tadashi Maemura; Mariko Okada-Hatakeyama; Osamu Ohara; Yoshihiro Kawaoka; Yoshimasa Takahashi; Toshitada Takemori; Masato Kubo
Journal:  Nat Immunol       Date:  2016-10-31       Impact factor: 25.606

Review 9.  Spatial and functional heterogeneity of follicular helper T cells in autoimmunity.

Authors:  Abhinav Seth; Joe Craft
Journal:  Curr Opin Immunol       Date:  2019-07-30       Impact factor: 7.486

10.  Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease.

Authors:  Angela M Floden; Tammy Gonzalez; Robert A Gaultney; Catherine A Brissette
Journal:  Clin Vaccine Immunol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.